Quick Answer
Regencell Bioscience Holdings Ltd reported Shares Outstanding of 494.49 million shares for fiscal year 2025.
Regencell Bioscience Holdings Ltd Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 494.49M | +0.0% |
| 2024 | 494.49M | +3700.0% |
| 2023 | 13.01M | +0.0% |
| 2022 | 13.01M | +30.1% |
| 2021 | 10.00M | +0.0% |
| 2020 | 10.00M | — |
- Regencell Bioscience Holdings Ltd showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Regencell Bioscience Holdings Ltd’s shares outstanding has grown by 4844.9% (from 10.00 million shares to 494.49 million shares).
- The most recent figure is from Regencell Bioscience Holdings Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on October 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: